Enterobiome Accelerates 'Revenue-First' Strategy with U.S. Launch of 'FLOUREN&apos... 유진희 2026.01.06 오후 05:24 Celltrion Mulls U.S. Plant to Counter Expected Tariffs 송영두 2025.05.07 오전 09:22 Celltrion, Tapped for API Facility Buy 김진수 2025.07.29 오전 10:49 Celltrion completes acquisition of Lilly’s U.S. plant, launches $470m CMO business 송영두 2026.01.02 오전 08:03 Celltrion, Track to Achieve 5 Trillion won in Annual Revenue This Year with Successful U.S. Expan... 신민준 2025.03.06 오전 10:10 Celltrion Nears $500M U.S. Plant Deal to Bypass Tariffs 송영두 2025.07.29 오후 01:17 HLB Starts Rivoceranib Site Planning to Diversify Supply Chain 김진수 2025.04.01 오후 04:51 로딩중..